Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

NCT06038318 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT06038318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06038318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 16, 2023
Completion date
May 1, 2027
Enrollment
325 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, stress